NEW YORK, NY / ACCESSWIRE / September 16, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Insperity, Inc. (NYSE:NSP)
Class Period: February 11, 2019 - February 11, 2020
Lead Plaintiff Deadline: September 21, 2020
The NSP lawsuit alleges Insperity, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (a) the Company had failed to negotiate appropriate rates with its customers for employee benefit plans and did not adequately disclose the risk of large medical claims from these plans; (b) Insperity was experiencing an adverse trend of large medical claims; (c) as a mitigating measure, the Company would be forced to increase the cost of its employee benefit plans, causing stunted customer growth and reduced customer retention; and (d) the foregoing issues were reasonably likely to, and would, materially impact Insperity's financial results.
Learn about your recoverable losses in NSP: http://www.kleinstocklaw.com/pslra-1/insperity-inc-loss-submission-form?id=9330&from=1
Vaxart, Inc. (NASDAQ:VXRT)
Class Period: June 25, 2020 - July 25, 2020
Lead Plaintiff Deadline: October 23, 2020
The VXRT lawsuit alleges that Vaxart, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.
Learn about your recoverable losses in VXRT: http://www.kleinstocklaw.com/pslra-1/vaxart-inc-loss-submission-form?id=9330&from=1
Coty Inc. (NYSE:COTY)
Class Period: October 3, 2016 - May 28, 2020
Lead Plaintiff Deadline: November 3, 2020
Coty Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) despite being no stranger to beauty brand acquisitions, Coty did not have adequate processes and procedures in place to assess and properly value the P&G Specialty Beauty Business and Kylie Cosmetics acquisitions; (2) as a result, Coty had overpaid for the P&G Specialty Beauty Business and Kylie Cosmetics; (3) Coty did not have adequate infrastructure to smoothly integrate and support the beauty brands that it acquired from P&G, including an adequate supply chain; (4) as a result of its inadequate infrastructure, Coty was not successfully integrating the beauty brands it acquired from P&G and not delivering synergies from the acquisition; and (5) as a result of the foregoing, Coty's financial statements and Defendants' statements about Coty's business, operations, and prospects, were materially false and/or misleading at all relevant times.
Learn about your recoverable losses in COTY: http://www.kleinstocklaw.com/pslra-1/coty-inc-loss-submission-form?id=9330&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on accesswire.com: